Category: Friday Forensic
-
Berz-Erka: Livewell unhalts after 8 months as Eureka 93 (ERKA.C), rolls back 15:1, loses 90% of its value
We talked to the folks behind Livewell a lot, back in the day. Seemed a good deal, certainly a team that talked a good game. Even bought a little personally. But there was always a coda attached. The projections and plans were big. Maybe too big. Here’s me, the first time I covered them. Little…
-
Anatomy of a shit-show: Saint Jean Carbon (SJL.V) wants to be a fidget spinner
Over the last few years, we’ve shivved a lot of terrible companies trying to pull a fast one on investors and, almost always, when we do, we face a few weeks of abuse from that company’s faithful. When we said Imagination Park (IP.C) was a bullshit fantasy playing on most people’s ignorance of the virtual…
-
Relevium (RLV.V) hit by OTC promo request, reveals worst disclosure ever
We’re in the business of marketing companies to people who like to invest in stocks with a high risk/high reward mindset. Sometimes folks call us ‘pump and dumpers’, usually if they haven’t read our work, but we ultimately only write what we believe to be true and we have a track record of writing negative…
-
Fundamental hype: As US MSO’s struggle, is National Access Cannabis (META.V) building the Canadian alternative?
About eighteen months ago, National Access Cannabis (META.V) emerged as part II of the Chuck Rifici master plan of Canadian weed v2.0 domination. His v1.0 domination plan was a company called Tweed, which later became Canopy Growth Corp (WEED.T). At a current $19.5 billion market cap, I guess you’d call that one a win, but…
-
Namaste Technologies (N.V) finally posts financials, and they’re rife with bad scenes
If there’s anything good in the financial statements just posted by Namaste Technologies (N.V) – last thing on a Friday afternoon, naturally – it’s that they have a lot of cash, and we finally know just how badly the company was being run last year, before CEO Sean Dollinger was turfed out. The highlights aren’t…
-
Aphria (APHA.T) ‘Special Committee’ confirms short seller conflict of interest allegations
Several months ago, Aphria (APHA.T) lost a good chunk of its worth when short sellers accused the company executive and board of (in a nutshell) feathering their own nests by agreeing to acquire properties from themselves, for much inflated prices. Today, after a ridiculously long wait which involved the CEO stepping sideways from his position…
-
TGOD vs Wildflower: Underplaying your hand as opposed to overplaying it
Two news releases wafted past me yesterday that caused me to dig deeper than the words written on the page. This sometimes happens out of necessity – a company has to release news about a topic but can’t go into detail yet, or has bad news they don’t particularly want to run a highlighter over.…
-
Enough is enough: Time for Aphria’s (APHA.T) CEO Vic Neufeld to resign or be fired
It’s time to end the charade. Canadian licensed cannabis producer Aphria (APHA.T) has long been considered one of the ‘big three’ in the North American scene, which helped them benefit from institutional investment, pension fund allocations, and ETF involvement, and contributed to a long rising market cap that topped out in January 2017 at around $5…
